|
⚲
|
| Keyboard |
| Prospect Management Co III LLC
✚
|
|
|---|---|
| CRD # | 160582 |
| SEC # | 802-75539 |
| CIK # | 0001331894 |
| AUM | |
| Employees | |
| Phone | 650-327-8800 |
| Address | 3175 Hanover Street Palo Alto, CA 94304 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Prospect Associates II LP | 2012-03-29 | 0.1 M | |
| VC | Prospect Venture Partners III LP | 2012-03-29 | 8.4 M | |
| VC | Prospect Venture Partners LP | 2012-03-29 | 7.2 M | |
| VC | Prospect Ventures Partners II LP | 2012-03-29 | 1.8 M |
| AUM Breakdown | Accounts | AUM ($) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Discretionary | ||
| Discretionary | 0 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 0 | 0.0 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001331894] | |
| 4 | [0001331894] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Schnell David | |
| Prospect Venture Partners III L P | |
| Prospect Management Co III LLC | |
| Baxano Surgical Inc | |
| Kythera Biopharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kythera Biopharmaceuticals Inc KYTH
Common Stock
|
2012-10-16 | Conversion | 118,013 | ||
|
Kythera Biopharmaceuticals Inc KYTH
Common Stock
|
2012-10-16 | Conversion | 469,926 | ||
|
Kythera Biopharmaceuticals Inc KYTH
Common Stock
|
2012-10-16 | Conversion | 1,325,151 | ||
|
Kythera Biopharmaceuticals Inc KYTH
Common Stock
|
2012-10-16 | Conversion | 1,476 | ||
|
Kythera Biopharmaceuticals Inc KYTH
Series D Preferred Stock · derivative
|
2012-10-16 | Conversion | 118,013 | $0.00 | |
|
Kythera Biopharmaceuticals Inc KYTH
Series C Preferred Stock · derivative
|
2012-10-16 | Conversion | 469,926 | $0.00 | |
|
Kythera Biopharmaceuticals Inc KYTH
Series B Preferred Stock · derivative
|
2012-10-16 | Conversion | 1,314,831 | $0.00 | |
|
Kythera Biopharmaceuticals Inc KYTH
Series A Preferred Stock · derivative
|
2012-10-16 | Conversion | 1,476 | $0.00 |